Synthesis and biological activity of isoprenoid bisphosphonates
详细信息 查看全文
- 作者：Larry W. Shull ; Andrew J. Wiemer ; Raymond J. Hohl and David F. Wiemer
- 关键词：Bisphosphonate ; Post-translational processing ; Isoprenoid metabolism
- 刊名：Bioorganic and Medicinal Chemistry
- 出版年：2006
- 出版时间：15 June 2006
- 年：2006
- 卷：14
- 期：12
- 页码：4130-4136
- 全文大小：212 K
文摘
Bisphosphonates have been used in the clinic to treat osteoporosis and to reduce bone resorption and the accompanying pathological bone fractures that attend a number of malignancies including multiple myeloma and cancers of the prostate, breast, and lung. There is also evidence that some bisphosphonates have direct anticancer activity. Expansion of the current class of bisphosphonates may lead to compounds that more selectively and potently target these cancers through inhibition of the mevalonate pathway. To this end, a set of dialkyl bisphosphonates bearing isoprenoid chains of varying lengths has been synthesized. Some of these compounds were found to have biological activity on post-translational processing of the oncogenic small GTPases, Ras and Rap1a, in human-derived K562 leukemia cells. Most importantly, these compounds impair protein geranylgeranylation and not protein farnesylation.